- Exchange: Natl India
- Sector: Consumer, Non-cyclical
- Industry: Pharmaceuticals
- Sub-Industry: Medical-Drugs
Ranbaxy Laboratories Ltd
Add to PortfolioRBXY:IN
532.60 INR 3.30 0.62%As of 03:39:17 ET on 05/30/2012.
Snapshot for Ranbaxy Laboratories Ltd (RBXY)
| Open: | 538.70 | Day's Range: | 531.10 - 540.00 | Volume: | 526,241 | Bid: | 532.60 |
|---|---|---|---|---|---|---|---|
| Previous Close: | 535.90 | 52wk Range: | 365.50 - 570.00 | 1-Yr Rtn: | -0.75% | Ask: | 532.75 |
Key Statistics for RBXY
| Current P/E Ratio (ttm) | - |
|---|---|
| Estimated P/E (12/2012) | 14.1288 |
| Earnings Per Share (INR) (ttm) | -68.8065 |
| Est. EPS (INR) (12/2012) | 37.6960 |
| Est. PEG Ratio | 0.6493 |
| Market Cap (M INR) | 224,817.16 |
| Shares Outstanding (M) | 422.11 |
| Enterprise Value (M INR) (ttm) | 240,315.72 |
| Enterprise Value/EBITDA (ttm) | 11.06 |
| Price/Book (mrq) | 7.8329 |
| Price/Sale (ttm) | 2.2089 |
| Dividend Indicated Gross Yield | 0.0000 |
| Next Earnings Announcement | 02/22/2013 |
More RBXY Key Statistics
mrq = Most Recent Quarter; ttm = Trailing Twelve Months
Financials for RBXY
- Operating
- Investing
- Financing (M/INR)
Company Profile & Key Executives for RBXY
Ranbaxy Laboratories Limited manufactures and distributes a wide range of pharmaceutical products. The Company makes multisource antibiotics, analgesics, anti-inflammatory drugs and anti-ulcerant/gastrointestinal drugs such as "Roscillin" (Ampicillin), "Cifran" (Ciprofloxacin) and "Sporidex" (Cephalexin).
| Tsutomu UneChairman | Arun SawhneyCEO/Managing Director |
| Indrajit BanerjeePresident/CFO | Sudershan K AroraPres:Research & Dev |
Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.
Sponsored Links
Top Forex Trading Resources
Advertisement
Advertisement
Advertisements
Rate this Page